Northern Mariana Islands
Hepatitis B
Download HBV dataPrevalence of chronic HBV (HBsAg+)
National
DownloadValue (%) | Year | Type | Source |
---|---|---|---|
7.08 (5.89 - 8.14) | 2019 | Modelled | IHME |
7.27 (6.13 - 8.40) | 2018 | Modelled | IHME |
7.35 (6.15 - 8.62) | 2017 | Modelled | IHME |
7.32 (6.14 - 8.56) | 2016 | Modelled | IHME |
7.28 (6.05 - 8.63) | 2015 | Modelled | IHME |
7.23 (6.03 - 8.57) | 2014 | Modelled | IHME |
7.17 (5.99 - 8.48) | 2013 | Modelled | IHME |
7.11 (5.95 - 8.42) | 2012 | Modelled | IHME |
7.05 (5.89 - 8.45) | 2011 | Modelled | IHME |
6.99 (5.77 - 8.58) | 2010 | Modelled | IHME |
6.93 (5.78 - 8.43) | 2009 | Modelled | IHME |
6.87 (5.77 - 8.25) | 2008 | Modelled | IHME |
6.81 (5.70 - 8.12) | 2007 | Modelled | IHME |
6.75 (5.61 - 7.96) | 2006 | Modelled | IHME |
6.69 (5.49 - 7.86) | 2005 | Modelled | IHME |
6.62 (5.49 - 7.72) | 2004 | Modelled | IHME |
6.54 (5.42 - 7.62) | 2003 | Modelled | IHME |
6.46 (5.36 - 7.58) | 2002 | Modelled | IHME |
6.4 (5.30 - 7.50) | 2001 | Modelled | IHME |
6.37 (5.28 - 7.53) | 2000 | Modelled | IHME |
6.39 (5.34 - 7.52) | 1999 | Modelled | IHME |
6.44 (5.40 - 7.56) | 1998 | Modelled | IHME |
6.49 (5.46 - 7.60) | 1997 | Modelled | IHME |
6.54 (5.52 - 7.64) | 1996 | Modelled | IHME |
6.56 (5.51 - 7.62) | 1995 | Modelled | IHME |
6.56 (5.53 - 7.55) | 1994 | Modelled | IHME |
6.56 (5.49 - 7.54) | 1993 | Modelled | IHME |
6.55 (5.46 - 7.54) | 1992 | Modelled | IHME |
6.54 (5.38 - 7.54) | 1991 | Modelled | IHME |
6.52 (5.28 - 7.54) | 1990 | Modelled | IHME |
Showing out of
Show more
Children under-5 years
DownloadValue (%) | Year | Type | Source |
---|---|---|---|
2.55 (1.78 - 3.52) | 2019 | Modelled | IHME |
2.57 (1.77 - 3.42) | 2018 | Modelled | IHME |
2.58 (1.75 - 3.43) | 2017 | Modelled | IHME |
2.58 (1.78 - 3.43) | 2016 | Modelled | IHME |
2.58 (1.78 - 3.47) | 2015 | Modelled | IHME |
2.57 (1.77 - 3.46) | 2014 | Modelled | IHME |
2.55 (1.75 - 3.45) | 2013 | Modelled | IHME |
2.53 (1.71 - 3.42) | 2012 | Modelled | IHME |
2.51 (1.68 - 3.39) | 2011 | Modelled | IHME |
2.51 (1.66 - 3.38) | 2010 | Modelled | IHME |
2.51 (1.67 - 3.37) | 2009 | Modelled | IHME |
2.53 (1.70 - 3.36) | 2008 | Modelled | IHME |
2.55 (1.73 - 3.38) | 2007 | Modelled | IHME |
2.57 (1.76 - 3.40) | 2006 | Modelled | IHME |
2.57 (1.77 - 3.44) | 2005 | Modelled | IHME |
2.54 (1.74 - 3.39) | 2004 | Modelled | IHME |
2.47 (1.69 - 3.30) | 2003 | Modelled | IHME |
2.39 (1.61 - 3.19) | 2002 | Modelled | IHME |
2.32 (1.56 - 3.11) | 2001 | Modelled | IHME |
2.29 (1.53 - 3.11) | 2000 | Modelled | IHME |
2.32 (1.56 - 3.13) | 1999 | Modelled | IHME |
2.38 (1.60 - 3.17) | 1998 | Modelled | IHME |
2.45 (1.65 - 3.25) | 1997 | Modelled | IHME |
2.51 (1.69 - 3.37) | 1996 | Modelled | IHME |
2.54 (1.71 - 3.42) | 1995 | Modelled | IHME |
2.54 (1.71 - 3.39) | 1994 | Modelled | IHME |
2.53 (1.71 - 3.35) | 1993 | Modelled | IHME |
2.51 (1.70 - 3.32) | 1992 | Modelled | IHME |
2.48 (1.70 - 3.28) | 1991 | Modelled | IHME |
2.43 (1.69 - 3.22) | 1990 | Modelled | IHME |
Showing out of
Show more
Number of people living with chronic HBV
National
DownloadValue | Year | Type | Source |
---|---|---|---|
2,958 (2,399 - 3,424) | 1990 | Modelled | IHME |
3,099 (2,553 - 3,574) | 1991 | Modelled | IHME |
3,138 (2,615 - 3,612) | 1992 | Modelled | IHME |
3,122 (2,616 - 3,588) | 1993 | Modelled | IHME |
3,125 (2,634 - 3,596) | 1994 | Modelled | IHME |
3,204 (2,692 - 3,719) | 1995 | Modelled | IHME |
3,386 (2,856 - 3,956) | 1996 | Modelled | IHME |
3,657 (3,076 - 4,279) | 1997 | Modelled | IHME |
4,001 (3,356 - 4,698) | 1998 | Modelled | IHME |
4,365 (3,643 - 5,134) | 1999 | Modelled | IHME |
4,641 (3,846 - 5,483) | 2000 | Modelled | IHME |
4,700 (3,894 - 5,514) | 2001 | Modelled | IHME |
4,569 (3,796 - 5,361) | 2002 | Modelled | IHME |
4,386 (3,635 - 5,113) | 2003 | Modelled | IHME |
4,249 (3,524 - 4,954) | 2004 | Modelled | IHME |
4,166 (3,417 - 4,890) | 2005 | Modelled | IHME |
4,115 (3,417 - 4,849) | 2006 | Modelled | IHME |
4,074 (3,407 - 4,854) | 2007 | Modelled | IHME |
4,016 (3,369 - 4,822) | 2008 | Modelled | IHME |
3,927 (3,274 - 4,773) | 2009 | Modelled | IHME |
3,812 (3,148 - 4,681) | 2010 | Modelled | IHME |
3,694 (3,088 - 4,429) | 2011 | Modelled | IHME |
3,589 (3,003 - 4,247) | 2012 | Modelled | IHME |
3,503 (2,925 - 4,140) | 2013 | Modelled | IHME |
3,432 (2,861 - 4,066) | 2014 | Modelled | IHME |
3,371 (2,801 - 3,997) | 2015 | Modelled | IHME |
3,319 (2,785 - 3,878) | 2016 | Modelled | IHME |
3,261 (2,729 - 3,821) | 2017 | Modelled | IHME |
3,156 (2,661 - 3,647) | 2018 | Modelled | IHME |
3,010 (2,501 - 3,460) | 2019 | Modelled | IHME |
Showing out of
Show more
HBV-related death rate
National
DownloadValue (per 100,000) | Year | Type | Source |
---|---|---|---|
19 (15 - 23.50) | 2019 | Modelled | IHME |
18.6 (14.70 - 22.80) | 2018 | Modelled | IHME |
18.2 (14.50 - 22.10) | 2017 | Modelled | IHME |
17.6 (14.10 - 21.30) | 2016 | Modelled | IHME |
16.7 (13.40 - 20.20) | 2015 | Modelled | IHME |
16 (12.90 - 19.30) | 2014 | Modelled | IHME |
15.5 (12.50 - 18.80) | 2013 | Modelled | IHME |
15.1 (12.20 - 18.30) | 2012 | Modelled | IHME |
14.6 (11.80 - 17.80) | 2011 | Modelled | IHME |
14 (11.30 - 17.10) | 2010 | Modelled | IHME |
13.4 (10.70 - 16.50) | 2009 | Modelled | IHME |
12.8 (10.20 - 15.80) | 2008 | Modelled | IHME |
12.2 (9.77 - 15.10) | 2007 | Modelled | IHME |
11.7 (9.32 - 14.40) | 2006 | Modelled | IHME |
11 (8.76 - 13.60) | 2005 | Modelled | IHME |
10.6 (8.42 - 13.20) | 2004 | Modelled | IHME |
10.3 (8.18 - 12.90) | 2003 | Modelled | IHME |
10.1 (8.01 - 12.70) | 2002 | Modelled | IHME |
10.1 (7.95 - 12.60) | 2001 | Modelled | IHME |
10.2 (7.99 - 12.70) | 2000 | Modelled | IHME |
10.4 (8.12 - 13) | 1999 | Modelled | IHME |
10.4 (8.03 - 13.10) | 1998 | Modelled | IHME |
10.5 (8.10 - 13.40) | 1997 | Modelled | IHME |
10.6 (8.10 - 13.60) | 1996 | Modelled | IHME |
10.6 (8.08 - 13.60) | 1995 | Modelled | IHME |
10.5 (7.95 - 13.70) | 1994 | Modelled | IHME |
10.6 (7.93 - 13.80) | 1993 | Modelled | IHME |
10.8 (8.07 - 14) | 1992 | Modelled | IHME |
11 (8.19 - 14.30) | 1991 | Modelled | IHME |
11.1 (8.26 - 14.80) | 1990 | Modelled | IHME |
Showing out of
Show more
HBV-related deaths
National
DownloadValue | Year | Type | Source |
---|---|---|---|
8 (6 - 10) | 2019 | Modelled | IHME |
8 (6 - 10) | 2018 | Modelled | IHME |
8 (6 - 10) | 2017 | Modelled | IHME |
8 (6 - 10) | 2016 | Modelled | IHME |
8 (6 - 9) | 2015 | Modelled | IHME |
8 (6 - 9) | 2014 | Modelled | IHME |
8 (6 - 9) | 2013 | Modelled | IHME |
8 (6 - 9) | 2012 | Modelled | IHME |
8 (6 - 9) | 2011 | Modelled | IHME |
8 (6 - 9) | 2010 | Modelled | IHME |
8 (6 - 9) | 2009 | Modelled | IHME |
7 (6 - 9) | 2008 | Modelled | IHME |
7 (6 - 9) | 2007 | Modelled | IHME |
7 (6 - 9) | 2006 | Modelled | IHME |
7 (5 - 8) | 2005 | Modelled | IHME |
7 (5 - 8) | 2004 | Modelled | IHME |
7 (5 - 9) | 2003 | Modelled | IHME |
7 (6 - 9) | 2002 | Modelled | IHME |
7 (6 - 9) | 2001 | Modelled | IHME |
7 (6 - 9) | 2000 | Modelled | IHME |
7 (6 - 9) | 1999 | Modelled | IHME |
6 (5 - 8) | 1998 | Modelled | IHME |
6 (5 - 8) | 1997 | Modelled | IHME |
5 (4 - 7) | 1996 | Modelled | IHME |
5 (4 - 7) | 1995 | Modelled | IHME |
5 (4 - 7) | 1994 | Modelled | IHME |
5 (4 - 7) | 1993 | Modelled | IHME |
5 (4 - 7) | 1992 | Modelled | IHME |
5 (4 - 7) | 1991 | Modelled | IHME |
5 (4 - 7) | 1990 | Modelled | IHME |
Showing out of
Show more
Percent of liver cancer deaths attributable to HBV
National
DownloadValue (%) | Year | Type | Source |
---|---|---|---|
59 (49 - 69) | 2019 | Modelled | IHME |
59 (50 - 69) | 2018 | Modelled | IHME |
60 (50 - 69) | 2017 | Modelled | IHME |
60 (51 - 69) | 2016 | Modelled | IHME |
60 (51 - 70) | 2015 | Modelled | IHME |
61 (52 - 70) | 2014 | Modelled | IHME |
61 (52 - 70) | 2013 | Modelled | IHME |
61 (53 - 70) | 2012 | Modelled | IHME |
61 (53 - 70) | 2011 | Modelled | IHME |
62 (53 - 70) | 2010 | Modelled | IHME |
62 (54 - 70) | 2009 | Modelled | IHME |
62 (54 - 70) | 2008 | Modelled | IHME |
62 (54 - 70) | 2007 | Modelled | IHME |
62 (54 - 70) | 2006 | Modelled | IHME |
62 (54 - 70) | 2005 | Modelled | IHME |
62 (54 - 70) | 2004 | Modelled | IHME |
62 (54 - 69) | 2003 | Modelled | IHME |
62 (54 - 69) | 2002 | Modelled | IHME |
62 (54 - 69) | 2001 | Modelled | IHME |
62 (54 - 69) | 2000 | Modelled | IHME |
61 (53 - 69) | 1999 | Modelled | IHME |
61 (53 - 68) | 1998 | Modelled | IHME |
60 (52 - 68) | 1997 | Modelled | IHME |
60 (52 - 68) | 1996 | Modelled | IHME |
60 (52 - 68) | 1995 | Modelled | IHME |
60 (52 - 68) | 1994 | Modelled | IHME |
60 (52 - 68) | 1993 | Modelled | IHME |
61 (53 - 69) | 1992 | Modelled | IHME |
61 (53 - 70) | 1991 | Modelled | IHME |
61 (53 - 70) | 1990 | Modelled | IHME |
Showing out of
Show more
Number of needles/syringes per PWID per year
People who inject drugs (PWID)
DownloadValue | Year | Type | Source |
---|---|---|---|
0 (0 - 0) | 2016 | Survey/reported | Harm Reduction International, 2016 |
Percent of PWID accessing OST
People who inject drugs (PWID)
DownloadValue (%) | Year | Type | Source |
---|---|---|---|
0 | 2016 | Survey/reported | Harm Reduction International, 2016 |
Eligible for HBV generic medicines
Eligible for HCV generic medicines
Hepatitis C
Download HCV dataPrevalence of chronic HCV (RNA+/cAg)
National
DownloadValue (%) | Year | Type | Source |
---|---|---|---|
0.55 (0.45 - 0.68) | 2019 | Modelled | IHME |
0.55 (0.44 - 0.67) | 2018 | Modelled | IHME |
0.55 (0.44 - 0.67) | 2017 | Modelled | IHME |
0.54 (0.44 - 0.66) | 2016 | Modelled | IHME |
0.54 (0.44 - 0.67) | 2015 | Modelled | IHME |
0.54 (0.44 - 0.66) | 2014 | Modelled | IHME |
0.54 (0.44 - 0.67) | 2013 | Modelled | IHME |
0.54 (0.44 - 0.67) | 2012 | Modelled | IHME |
0.54 (0.44 - 0.67) | 2011 | Modelled | IHME |
0.54 (0.43 - 0.67) | 2010 | Modelled | IHME |
0.54 (0.43 - 0.66) | 2009 | Modelled | IHME |
0.54 (0.42 - 0.66) | 2008 | Modelled | IHME |
0.53 (0.42 - 0.65) | 2007 | Modelled | IHME |
0.53 (0.42 - 0.65) | 2006 | Modelled | IHME |
0.53 (0.42 - 0.64) | 2005 | Modelled | IHME |
0.53 (0.42 - 0.65) | 2004 | Modelled | IHME |
0.54 (0.43 - 0.67) | 2003 | Modelled | IHME |
0.56 (0.44 - 0.68) | 2002 | Modelled | IHME |
0.57 (0.45 - 0.70) | 2001 | Modelled | IHME |
0.57 (0.45 - 0.71) | 2000 | Modelled | IHME |
0.57 (0.46 - 0.71) | 1999 | Modelled | IHME |
0.58 (0.46 - 0.71) | 1998 | Modelled | IHME |
0.58 (0.46 - 0.71) | 1997 | Modelled | IHME |
0.58 (0.46 - 0.71) | 1996 | Modelled | IHME |
0.58 (0.46 - 0.71) | 1995 | Modelled | IHME |
0.58 (0.46 - 0.71) | 1994 | Modelled | IHME |
0.58 (0.46 - 0.72) | 1993 | Modelled | IHME |
0.58 (0.46 - 0.72) | 1992 | Modelled | IHME |
0.58 (0.47 - 0.72) | 1991 | Modelled | IHME |
0.58 (0.47 - 0.73) | 1990 | Modelled | IHME |
Showing out of
Show more
Number of people living with chronic HCV (RNA+/cAg)
National
DownloadValue | Year | Type | Source |
---|---|---|---|
265 (211 - 330) | 1990 | Modelled | IHME |
276 (221 - 342) | 1991 | Modelled | IHME |
279 (222 - 343) | 1992 | Modelled | IHME |
276 (221 - 341) | 1993 | Modelled | IHME |
276 (220 - 339) | 1994 | Modelled | IHME |
283 (224 - 348) | 1995 | Modelled | IHME |
299 (239 - 366) | 1996 | Modelled | IHME |
325 (259 - 398) | 1997 | Modelled | IHME |
358 (285 - 438) | 1998 | Modelled | IHME |
392 (312 - 483) | 1999 | Modelled | IHME |
417 (331 - 514) | 2000 | Modelled | IHME |
416 (331 - 514) | 2001 | Modelled | IHME |
393 (313 - 484) | 2002 | Modelled | IHME |
364 (289 - 447) | 2003 | Modelled | IHME |
342 (270 - 419) | 2004 | Modelled | IHME |
329 (259 - 401) | 2005 | Modelled | IHME |
322 (254 - 393) | 2006 | Modelled | IHME |
318 (252 - 389) | 2007 | Modelled | IHME |
313 (248 - 383) | 2008 | Modelled | IHME |
305 (243 - 376) | 2009 | Modelled | IHME |
295 (236 - 364) | 2010 | Modelled | IHME |
283 (228 - 350) | 2011 | Modelled | IHME |
273 (220 - 336) | 2012 | Modelled | IHME |
263 (215 - 325) | 2013 | Modelled | IHME |
256 (207 - 316) | 2014 | Modelled | IHME |
250 (203 - 310) | 2015 | Modelled | IHME |
246 (199 - 301) | 2016 | Modelled | IHME |
243 (195 - 297) | 2017 | Modelled | IHME |
239 (192 - 291) | 2018 | Modelled | IHME |
235 (189 - 288) | 2019 | Modelled | IHME |
Showing out of
Show more
HCV-related death rate
National
DownloadValue (per 100,000) | Year | Type | Source |
---|---|---|---|
7.78 (5.63 - 10.80) | 2019 | Modelled | IHME |
7.61 (5.49 - 10.50) | 2018 | Modelled | IHME |
7.41 (5.35 - 10.10) | 2017 | Modelled | IHME |
7.15 (5.22 - 9.67) | 2016 | Modelled | IHME |
6.84 (5.04 - 9.31) | 2015 | Modelled | IHME |
6.58 (4.87 - 8.91) | 2014 | Modelled | IHME |
6.43 (4.73 - 8.60) | 2013 | Modelled | IHME |
6.28 (4.61 - 8.44) | 2012 | Modelled | IHME |
6.13 (4.48 - 8.21) | 2011 | Modelled | IHME |
5.93 (4.33 - 7.95) | 2010 | Modelled | IHME |
5.72 (4.19 - 7.70) | 2009 | Modelled | IHME |
5.53 (4.06 - 7.47) | 2008 | Modelled | IHME |
5.35 (3.89 - 7.26) | 2007 | Modelled | IHME |
5.16 (3.77 - 7.04) | 2006 | Modelled | IHME |
4.9 (3.58 - 6.68) | 2005 | Modelled | IHME |
4.77 (3.49 - 6.51) | 2004 | Modelled | IHME |
4.73 (3.48 - 6.42) | 2003 | Modelled | IHME |
4.73 (3.46 - 6.39) | 2002 | Modelled | IHME |
4.78 (3.49 - 6.48) | 2001 | Modelled | IHME |
4.89 (3.55 - 6.68) | 2000 | Modelled | IHME |
5.08 (3.67 - 7) | 1999 | Modelled | IHME |
5.11 (3.69 - 7.06) | 1998 | Modelled | IHME |
5.27 (3.79 - 7.31) | 1997 | Modelled | IHME |
5.34 (3.82 - 7.36) | 1996 | Modelled | IHME |
5.35 (3.86 - 7.29) | 1995 | Modelled | IHME |
5.32 (3.81 - 7.32) | 1994 | Modelled | IHME |
5.37 (3.80 - 7.50) | 1993 | Modelled | IHME |
5.45 (3.85 - 7.63) | 1992 | Modelled | IHME |
5.54 (3.87 - 7.81) | 1991 | Modelled | IHME |
5.61 (3.93 - 7.96) | 1990 | Modelled | IHME |
Showing out of
Show more
HCV-related deaths
National
DownloadValue | Year | Type | Source |
---|---|---|---|
3 (2 - 5) | 2019 | Modelled | IHME |
3 (2 - 5) | 2018 | Modelled | IHME |
3 (2 - 4) | 2017 | Modelled | IHME |
3 (2 - 4) | 2016 | Modelled | IHME |
3 (2 - 4) | 2015 | Modelled | IHME |
3 (2 - 4) | 2014 | Modelled | IHME |
3 (2 - 4) | 2013 | Modelled | IHME |
3 (2 - 4) | 2012 | Modelled | IHME |
3 (2 - 4) | 2011 | Modelled | IHME |
3 (2 - 4) | 2010 | Modelled | IHME |
3 (2 - 4) | 2009 | Modelled | IHME |
3 (2 - 4) | 2008 | Modelled | IHME |
3 (2 - 4) | 2007 | Modelled | IHME |
3 (2 - 4) | 2006 | Modelled | IHME |
3 (2 - 4) | 2005 | Modelled | IHME |
3 (2 - 4) | 2004 | Modelled | IHME |
3 (2 - 4) | 2003 | Modelled | IHME |
3 (2 - 5) | 2002 | Modelled | IHME |
4 (3 - 5) | 2001 | Modelled | IHME |
4 (3 - 5) | 2000 | Modelled | IHME |
3 (3 - 5) | 1999 | Modelled | IHME |
3 (2 - 4) | 1998 | Modelled | IHME |
3 (2 - 4) | 1997 | Modelled | IHME |
3 (2 - 4) | 1996 | Modelled | IHME |
3 (2 - 4) | 1995 | Modelled | IHME |
3 (2 - 3) | 1994 | Modelled | IHME |
3 (2 - 4) | 1993 | Modelled | IHME |
3 (2 - 4) | 1992 | Modelled | IHME |
3 (2 - 4) | 1991 | Modelled | IHME |
3 (2 - 4) | 1990 | Modelled | IHME |
Showing out of
Show more
Percent of liver cancer deaths attributable to HCV
National
DownloadValue (%) | Year | Type | Source |
---|---|---|---|
16 (10 - 24) | 2019 | Modelled | IHME |
16 (10 - 23) | 2018 | Modelled | IHME |
16 (10 - 22) | 2017 | Modelled | IHME |
16 (10 - 22) | 2016 | Modelled | IHME |
16 (10 - 22) | 2015 | Modelled | IHME |
15 (10 - 22) | 2014 | Modelled | IHME |
15 (10 - 21) | 2013 | Modelled | IHME |
15 (10 - 21) | 2012 | Modelled | IHME |
15 (10 - 21) | 2011 | Modelled | IHME |
15 (10 - 20) | 2010 | Modelled | IHME |
15 (10 - 20) | 2009 | Modelled | IHME |
15 (10 - 20) | 2008 | Modelled | IHME |
14 (10 - 20) | 2007 | Modelled | IHME |
14 (10 - 20) | 2006 | Modelled | IHME |
14 (10 - 20) | 2005 | Modelled | IHME |
14 (10 - 19) | 2004 | Modelled | IHME |
14 (10 - 19) | 2003 | Modelled | IHME |
14 (10 - 19) | 2002 | Modelled | IHME |
14 (10 - 19) | 2001 | Modelled | IHME |
14 (10 - 20) | 2000 | Modelled | IHME |
15 (10 - 20) | 1999 | Modelled | IHME |
15 (10 - 21) | 1998 | Modelled | IHME |
15 (11 - 21) | 1997 | Modelled | IHME |
16 (11 - 21) | 1996 | Modelled | IHME |
16 (11 - 21) | 1995 | Modelled | IHME |
16 (11 - 21) | 1994 | Modelled | IHME |
16 (11 - 21) | 1993 | Modelled | IHME |
16 (10 - 21) | 1992 | Modelled | IHME |
15 (10 - 21) | 1991 | Modelled | IHME |
16 (10 - 21) | 1990 | Modelled | IHME |
Showing out of
Show more
Number of needles/syringes per PWID per year
People who inject drugs (PWID)
DownloadValue | Year | Type | Source |
---|---|---|---|
0 (0 - 0) | 2016 | Survey/reported | Harm Reduction International, 2016 |
Percent of PWID accessing OST
People who inject drugs (PWID)
DownloadValue (%) | Year | Type | Source |
---|---|---|---|
0 | 2016 | Survey/reported | Harm Reduction International, 2016 |
Eligible for HBV generic medicines
Eligible for HCV generic medicines
Overview
Prevalence (national)
Modelled
Survey/surveillance
No data available
No data available
Hepatitis related deaths (national)
Prevalence < 5
HBV
2.55
(%)
2019, latest modelled
(1.78 - 3.52(%))
IHME
Prevalence PWID
No data available
Birth dose vaccination coverage (national)
Survey/surveillance
No data available
Eligible for HBV generic medicines
Eligible for HCV generic medicines